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The Baron’s complaint
Mark A Jobling
Puzzlingly for those who actually lived through the decade,
a 1980s revival has been underway for a good while. We’ve
seen the renaissance of power dressing, leg warmers, big
hair and the shoulder pad; Heaven 17 and the Human
League have been on tour again.
There’sf o n d n e s sf o rt h e s ee l e m e n t so f1 9 8 0 sl i f e ,
cheesy though they may have been. The politicians of
t h et i m et e n d e dt ob em u c hm o r ep o l a r i s i n g .T w os u c h
figures, one deceased and one retired, made the news
again recently. On US Independence Day, a new statue
was unveiled outside the American Embassy in London.
Ten feet tall, and cast in a chocolaty bronze, Ronald Rea-
gan now smiles benignly down on passersby. One week
previously, an iconic handbag belonging to Margaret
Thatcher was sold for £25,000 at a charity auction.
Apart from being a mutual admiration society, these old
transatlantic allies were united by a physical condition:
They both suffered from something called Dupuytren’s
contracture. ‘Whose what?’, you are probably asking your-
self. The overbearing and authoritarian Baron Guillaume
Dupuytren was a French physician, and Napoleon Bona-
parte’s doctor. He described this thickening in the palm of
the hand, and the progressive and permanent contraction
of the fingers [1], in a lecture in 1831, and gave his name
to the condition despite not being the first to report it.
The contracture severely limits hand function; it can be
corrected by surgery, but may recur, and can eventually
require amputations.
Dupuytren’s disease is more prevalent among men than
women, and appears rather late in life: its average age of
onset is 60 years. For a geneticist, the interest comes
from its reported heritability: it possesses an Online
Mendelian Inheritance in Man database number
[OMIM:126900] and is described as a dominant trait
with incomplete penetrance as well as the commonest
heritable disorder of connective tissue. One linkage study
in a five-generation Swedish pedigree [2] fits this pattern
and provides evidence for a locus on chromosome 16q.
For the historian, however, the condition is intriguing
because of its alleged population distribution and origins:
It is widely regarded as a ‘Viking disease’.
The condition was always known to be relatively com-
mon in northern Europe and rare in other continents,
but the Viking connection was first suggested explicitly
in a paper published in 1962 [3] in which the frequency
was found to be highest in Danes. The author hypothe-
sised that, if the condition arose within the ‘Nordic racial
group’, then its distribution elsewhere might be explained
on the basis of Viking migration.
In a nice example of an interdisciplinary study [4],
David Elliot, a plastic surgeon, and Diana Whaley, a pro-
fessor of early medieval studies, collaborated to identify
and interpret, in the medieval Viking sagas, descriptions
of conditions that might have been Dupuytren’s. They
discovered four accounts of miracles from Orkney and
Iceland in which people with disabled hands were cured.
For example, from the 12th-century Longer Saga of Mag-
nus: ‘There was a man called Sigurðr, from north in Shet-
land. He had a crippled hand such that all the fingers lay
in the palm. He went to the holy shrine ... and there
found healing, with fingers straight and supple for all his
needs.’
My research group has been interested in Viking ances-
try in Britain for a while, and I first encountered Dupuyt-
ren’s in the flesh after addressing DNA donors in
Knowsley, near Liverpool. The condition was not men-
tioned in my talk, but afterwards an elderly man asked a
question. “Do you know anything about this?,” he asked.
He held up a hand with ring and little fingers tightly con-
tracted into his palm. His brother and father, he said, were
sufferers too. I asked if anyone else in the audience had
the condition, and, to my surprise, about 10 of the 200
people there said they did. The frequency revealed by this
straw poll seemed remarkably high, and I wondered if the
excess Norse Viking ancestry indicated in this population
by our own Y-chromosomal studies [5] was connected to
this high incidence. There again, maybe it was ascertain-
ment bias: someone develops Dupuytren’s contracture, is
told ‘it’s a Viking disease’, gets interested in their own pos-
sible Viking heritage, and so enrols in our study and
comes to my talk.
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ren’s can be much higher than this. There is confusion
due to variable diagnostic criteria; differences in partici-
pant age; environmental issues, including manual work,
smoking and alcohol; and risk factors such as diabetes or
epilepsy [6]. However, in most populations of northern
European ancestry, the prevalence of Dupuytren’s is more
than 10%, and in a Norwegian sample of males between
70 and 79 years of age, the figure is a remarkable 35%.
Back to the genetics. Unfortunately, since the population
surveys were undertaken by surgeons and physicians
rather than geneticists, most paid no attention to family
history or mode of inheritance. But if Dupuytren’si s
caused by dominant alleles, and if there is a Viking foun-
der mutation, then surely it should be easy to find the
gene and map its migrations along with those of the voya-
gers who carried it. Alas, if only things were so simple. A
recent genome-wide association study [7] of Dutch,
German and British cases found nine loci associated with
susceptibility to Dupuytren’s contracture, six of which
involved the Wnt signalling pathway. All have quite mod-
est effects (the largest odds ratio is 1.98), and there is no
sign of the 16q locus suggested by the Swedish family
study.
So the Baron’s complaint is probably more complex
than it appears. There is certainly a need for more family
studies, and perhaps a proper look at Scandinavia. But,
sadly, it seems possible that the intriguing tale of the ‘Vik-
ing disease’ might be a myth (like the horned helmet and
the addiction to rape and pillage) that people just want to
be true. As the sufferer Lady Thatcher once said, ‘Nothing
is more obstinate than a fashionable consensus’.
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